Celldex Therapeutics Inc
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzo… Read more
Celldex Therapeutics Inc (CLDX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.121x
Based on the latest financial reports, Celldex Therapeutics Inc (CLDX) has a cash flow conversion efficiency ratio of -0.121x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-63.94 Million) by net assets ($527.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Celldex Therapeutics Inc - Cash Flow Conversion Efficiency Trend (1986–2025)
This chart illustrates how Celldex Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Celldex Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Celldex Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yunnan Wenshan Electric Power Co Ltd
SHG:600995
|
0.050x |
|
MULTIPLAN EMPREENDIMENTOS IMOB
PINK:MLTTY
|
0.088x |
|
KRUK Spólka Akcyjna
PINK:KRKKF
|
-0.025x |
|
China Huarong Asset Management Co. Ltd
F:CHE
|
0.432x |
|
Regis Resources Ltd
PINK:RGRNF
|
0.336x |
|
SOL S.p.A
LSE:0NJP
|
N/A |
|
Hycroft Mining Holding Corporation
NASDAQ:HYMC
|
-0.072x |
|
Vietnam Dairy Products JSC
VN:VNM
|
0.050x |
Annual Cash Flow Conversion Efficiency for Celldex Therapeutics Inc (1986–2025)
The table below shows the annual cash flow conversion efficiency of Celldex Therapeutics Inc from 1986 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $527.16 Million | $-210.94 Million | -0.400x | -89.45% |
| 2024-12-31 | $747.00 Million | $-157.78 Million | -0.211x | +15.51% |
| 2023-12-31 | $429.17 Million | $-107.29 Million | -0.250x | +21.38% |
| 2022-12-31 | $326.20 Million | $-103.73 Million | -0.318x | -119.00% |
| 2021-12-31 | $419.48 Million | $-60.91 Million | -0.145x | +24.76% |
| 2020-12-31 | $209.36 Million | $-40.40 Million | -0.193x | +60.90% |
| 2019-12-31 | $94.03 Million | $-46.41 Million | -0.494x | +18.60% |
| 2018-12-31 | $124.06 Million | $-75.23 Million | -0.606x | -43.44% |
| 2017-12-31 | $236.37 Million | $-99.93 Million | -0.423x | +0.72% |
| 2016-12-31 | $265.43 Million | $-113.04 Million | -0.426x | -24.93% |
| 2015-12-31 | $290.11 Million | $-98.89 Million | -0.341x | +28.94% |
| 2014-12-31 | $211.66 Million | $-101.54 Million | -0.480x | -126.71% |
| 2013-12-31 | $319.80 Million | $-67.67 Million | -0.212x | +59.29% |
| 2012-12-31 | $95.77 Million | $-49.78 Million | -0.520x | -0.18% |
| 2011-12-31 | $68.72 Million | $-35.66 Million | -0.519x | -28.57% |
| 2010-12-31 | $75.25 Million | $-30.37 Million | -0.404x | +0.33% |
| 2009-12-31 | $73.77 Million | $-29.87 Million | -0.405x | -140.17% |
| 2008-12-31 | $18.13 Million | $18.28 Million | 1.008x | -0.54% |
| 2007-12-31 | $-19.04 Million | $-19.30 Million | 1.014x | -91.89% |
| 2006-12-31 | $2.16 Million | $27.00 Million | 12.494x | +4437.96% |
| 2005-12-31 | $20.89 Million | $-6.02 Million | -0.288x | -6.91% |
| 2004-12-31 | $38.41 Million | $-10.35 Million | -0.269x | +35.92% |
| 2003-12-31 | $27.92 Million | $-11.74 Million | -0.420x | +20.89% |
| 2002-12-31 | $31.34 Million | $-16.66 Million | -0.531x | -15.53% |
| 2001-12-31 | $45.27 Million | $-20.83 Million | -0.460x | -459.83% |
| 2000-12-31 | $53.93 Million | $-4.43 Million | -0.082x | +83.24% |
| 1999-12-31 | $17.41 Million | $-8.54 Million | -0.490x | -3.59% |
| 1998-12-31 | $18.80 Million | $-8.90 Million | -0.473x | +61.27% |
| 1997-12-31 | $6.30 Million | $-7.70 Million | -1.222x | -96.56% |
| 1996-12-31 | $15.60 Million | $-9.70 Million | -0.622x | -25.93% |
| 1995-12-31 | $16.00 Million | $-7.90 Million | -0.494x | +4.51% |
| 1994-12-31 | $17.60 Million | $-9.10 Million | -0.517x | -173.56% |
| 1993-12-31 | $29.10 Million | $-5.50 Million | -0.189x | +3.08% |
| 1992-12-31 | $20.00 Million | $-3.90 Million | -0.195x | +32.40% |
| 1991-12-31 | $10.40 Million | $-3.00 Million | -0.288x | 0.00% |
| 1990-12-31 | $10.40 Million | $-3.00 Million | -0.288x | -439.84% |
| 1989-12-31 | $13.10 Million | $-700.00K | -0.053x | +35.88% |
| 1988-12-31 | $8.40 Million | $-700.00K | -0.083x | -107.05% |
| 1986-12-31 | $10.40 Million | $12.30 Million | 1.183x | -- |